Home » Topics » BioWorld Science

BioWorld Science
RSS

Polaris collaborates with MD Anderson Cancer Center to utilize immunotherapy platform

May 14, 2018

Poseida Therapeutics presents clinical data on P-BCMA-101 for relapsed/refractory multiple myeloma

May 14, 2018

Beam Therapeutics launches with focus on creating precision genetic medicines through base editing

May 14, 2018

Human evaluation of CAR T cells targeting ROR1 underway

May 14, 2018

Medigene and bluebird bio expand TCR alliance

May 14, 2018

Tumor growth inhibition seen with Jubilant Biosys LSD1/HDAC inhibitors

May 14, 2018

Phase II trial in China studies SHR-1210 for advanced biliary tract cancer

May 14, 2018

Inovio studies VGX-3100 in new phase II trial for HPV-16 or -18 related anal or peri-anal HSIL

May 14, 2018

Sanofi announces success of initial tender offer for acquisition of Ablynx

May 14, 2018

Ono Pharmaceutical reflects on achievements of fourth quarter of fiscal 2017

May 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...